The Future of Frontline CAR T in Mantle Cell Lymphoma: Brad S. Kahl, MD
The professor of medicine at Washington University School of Medicine in St. Louis discussed the potential utility of frontline CAR T-cell therapy in mantle cell lymphoma.
Dr. Kahl on Remaining Challenges With CAR T-Cell Therapy in DLBCL
Brad S. Kahl, MD, discusses remaining challenges with CAR T-cell therapy in diffuse large B-cell lymphoma.
Maintenance Therapy in Mantle Cell Lymphoma
This video reviews different strategies for maintenance therapy in mantle cell lymphoma, as well as highlighting upcoming research in this setting.
2 Commerce Drive Cranbury, NJ 08512